Skip to main content
Top
Published in: European Radiology 6/2018

01-06-2018 | Interventional

Feasibility study of MR-guided transgluteal targeted in-bore biopsy for suspicious lesions of the prostate at 3 Tesla using a freehand approach

Authors: Frank Fischbach, Lukas Wien, Sascha Krueger, Bernhard Schnackenburg, Daniel Baumunk, Björn Friebe, Martin Schostak, Jens Ricke, Katharina Fischbach

Published in: European Radiology | Issue 6/2018

Login to get access

Abstract

Objective

The aim of our study was (1) to establish an in-bore targeted biopsy of suspicious prostate lesions, avoiding bowel penetration using a transgluteal approach and (2) to assess operator setup, patient comfort and safety aspects in the clinical setting for freehand real-time MR-guidance established for percutaneous procedures in an open MR-scanner.

Material and methods

30 patients with suspect prostate lesions were biopsied in a cylindrical 3T-MRI system using a transgluteal approach in freehand technique. One to three biopsies were sampled using continuous dynamic imaging. Size, location and visibility of the lesion, intervention time, needle artefact size, interventional complications and histopathological diagnosis were recorded.

Results

All biopsies were technically successful. Nineteen patients showed evidence of prostate carcinoma. Cancer detection rate was 50 % in patients with previously negative TRUS-biopsy. The average intervention time was 26 min including a learning curve as the time was 13 min by the end of the study. No antibiotic prophylaxis was performed as none of the patients showed signs of infection.

Conclusions

MR-guided targeted freehand biopsies of prostate lesions using a transgluteal approach are both technically feasible and time efficient in a standard closed-bore 3T-MR scanner as well as safe for the individual patient.

Key Points

Open-bore freehand interventional principles were adapted to closed-bore systems.
Prostate MR-guided freehand biopsies were feasible in a clinical setting.
A transgluteal approach provides a short and simplified work flow.
An inoculation of the prostate with bowel flora is avoided.
The intervention time is comparable to the stereotactic approach.
Literature
1.
go back to reference Bastian PJ, Bellmunt J, Bolla M et al (2014) European Association of Urology. EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update. Eur Urol 65:124–137CrossRefPubMed Bastian PJ, Bellmunt J, Bolla M et al (2014) European Association of Urology. EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update. Eur Urol 65:124–137CrossRefPubMed
2.
go back to reference Walz J, Graefen M, Chun FK et al (2006) High incidence of prostate cancer detected by saturation biopsy after previous negative biopsy series. Eur Urol 50:498–505CrossRefPubMed Walz J, Graefen M, Chun FK et al (2006) High incidence of prostate cancer detected by saturation biopsy after previous negative biopsy series. Eur Urol 50:498–505CrossRefPubMed
3.
go back to reference Haas GP, Delongchamps NB, Jones RF et al (2007) Needle biopsies on autopsy prostates: sensitivity of cancer detection based on true prevalence. J Natl Cancer Inst 99:1484–1489CrossRefPubMed Haas GP, Delongchamps NB, Jones RF et al (2007) Needle biopsies on autopsy prostates: sensitivity of cancer detection based on true prevalence. J Natl Cancer Inst 99:1484–1489CrossRefPubMed
4.
go back to reference Fernandes ET, Sundaram CP, Long R et al (1997) Biopsy Gleason score: how does it correlate with the final pathological diagnosis in prostate cancer? Br J Urol 79:615–617CrossRefPubMed Fernandes ET, Sundaram CP, Long R et al (1997) Biopsy Gleason score: how does it correlate with the final pathological diagnosis in prostate cancer? Br J Urol 79:615–617CrossRefPubMed
5.
go back to reference Chun FK, Steuber T, Erbersdobler A et al (2006) Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology. Eur Urol 49:820–826CrossRefPubMed Chun FK, Steuber T, Erbersdobler A et al (2006) Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology. Eur Urol 49:820–826CrossRefPubMed
6.
go back to reference Schoots IG, Roobol MJ, Nieboer D et al (2015) Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis. Eur Urol 68:438–450CrossRefPubMed Schoots IG, Roobol MJ, Nieboer D et al (2015) Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis. Eur Urol 68:438–450CrossRefPubMed
8.
go back to reference Wegelin O, van Melick HH, Hooft L et al (2017) Comparing Three Different Techniques for Magnetic Resonance Imaging-targeted Prostate Biopsies: A Systematic Review of In-bore versus Magnetic Resonance Imaging-transrectal Ultrasound fusion versus Cognitive Registration. Is There a Preferred Technique? Eur Urol 71:517–531CrossRefPubMed Wegelin O, van Melick HH, Hooft L et al (2017) Comparing Three Different Techniques for Magnetic Resonance Imaging-targeted Prostate Biopsies: A Systematic Review of In-bore versus Magnetic Resonance Imaging-transrectal Ultrasound fusion versus Cognitive Registration. Is There a Preferred Technique? Eur Urol 71:517–531CrossRefPubMed
9.
go back to reference Arsov C, Rabenalt R, Blondin D et al (2015) Prospective randomized trial comparing magnetic resonance imaging (MRI)-guided in-bore biopsy to MRI-ultrasound fusion and transrectal ultrasound-guided prostate biopsy in patients with prior negative biopsies. Eur Urol 68:713–720CrossRefPubMed Arsov C, Rabenalt R, Blondin D et al (2015) Prospective randomized trial comparing magnetic resonance imaging (MRI)-guided in-bore biopsy to MRI-ultrasound fusion and transrectal ultrasound-guided prostate biopsy in patients with prior negative biopsies. Eur Urol 68:713–720CrossRefPubMed
10.
go back to reference Loeb S, van den Heuvel S, Zhu X et al (2012) Infectious complications and hospital admissions after prostate biopsy in a European randomized trial. Eur Urol 61:1110–1114CrossRefPubMed Loeb S, van den Heuvel S, Zhu X et al (2012) Infectious complications and hospital admissions after prostate biopsy in a European randomized trial. Eur Urol 61:1110–1114CrossRefPubMed
11.
go back to reference Fischbach F, Eggemann H, Bunke J et al (2012) MR-guided freehand biopsy of breast lesions in a 1.0-T open MR imager with a near-real-time interactive platform: preliminary experience. Radiology 265:359–370CrossRefPubMed Fischbach F, Eggemann H, Bunke J et al (2012) MR-guided freehand biopsy of breast lesions in a 1.0-T open MR imager with a near-real-time interactive platform: preliminary experience. Radiology 265:359–370CrossRefPubMed
12.
go back to reference Fischbach F, Porsch M, Krenzien F et al (2011) MR imaging guided percutaneous nephrostomy using a 1.0 Tesla open MR scanner. Cardiovasc Intervent Radiol 34:857–863CrossRefPubMed Fischbach F, Porsch M, Krenzien F et al (2011) MR imaging guided percutaneous nephrostomy using a 1.0 Tesla open MR scanner. Cardiovasc Intervent Radiol 34:857–863CrossRefPubMed
13.
go back to reference Fischbach F, Bunke J, Thormann M et al (2011) MR-guided freehand biopsy of liver lesions with fast continuous imaging using a 1.0-T open MRI scanner: experience in 50 patients. Cardiovasc Intervent Radiol 34:188–192CrossRefPubMed Fischbach F, Bunke J, Thormann M et al (2011) MR-guided freehand biopsy of liver lesions with fast continuous imaging using a 1.0-T open MRI scanner: experience in 50 patients. Cardiovasc Intervent Radiol 34:188–192CrossRefPubMed
14.
go back to reference Moore CM, Kasivisvanathan V, Eggener S et al (2013) START Consortium. Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group. Eur Urol 64:544–552CrossRefPubMed Moore CM, Kasivisvanathan V, Eggener S et al (2013) START Consortium. Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group. Eur Urol 64:544–552CrossRefPubMed
15.
go back to reference Vargas HA, Hötker AM, Goldman DA et al (2016) Updated prostate imaging reporting and data system (PIRADS v2) recommendations for the detection of clinically significant prostate cancer using multiparametric MRI: critical evaluation using whole-mount pathology as standard of reference. Eur Radiol 26:1606–1612CrossRefPubMed Vargas HA, Hötker AM, Goldman DA et al (2016) Updated prostate imaging reporting and data system (PIRADS v2) recommendations for the detection of clinically significant prostate cancer using multiparametric MRI: critical evaluation using whole-mount pathology as standard of reference. Eur Radiol 26:1606–1612CrossRefPubMed
16.
go back to reference Beyersdorff D, Winkel A, Hamm B et al (2005) MR imaging-guided prostate biopsy with a closed MR unit at 1.5 T: initial results. Radiology 234:576–581CrossRefPubMed Beyersdorff D, Winkel A, Hamm B et al (2005) MR imaging-guided prostate biopsy with a closed MR unit at 1.5 T: initial results. Radiology 234:576–581CrossRefPubMed
17.
go back to reference Hambrock T, Fütterer JJ, Huisman HJ et al (2008) Thirty-two-channel coil 3T magnetic resonance-guided biopsies of prostate tumor suspicious regions identified on multimodality 3T magnetic resonance imaging: technique and feasibility. Invest Radiol 43:686–694CrossRefPubMed Hambrock T, Fütterer JJ, Huisman HJ et al (2008) Thirty-two-channel coil 3T magnetic resonance-guided biopsies of prostate tumor suspicious regions identified on multimodality 3T magnetic resonance imaging: technique and feasibility. Invest Radiol 43:686–694CrossRefPubMed
18.
go back to reference Zangos S, Melzer A, Eichler K et al (2011) MR-compatible assistance system for biopsy in a high-field-strength system: initial results in patients with suspicious prostate lesions. Radiology 259:903–910CrossRefPubMed Zangos S, Melzer A, Eichler K et al (2011) MR-compatible assistance system for biopsy in a high-field-strength system: initial results in patients with suspicious prostate lesions. Radiology 259:903–910CrossRefPubMed
19.
go back to reference Gupta S, Nguyen HL, Morello FA Jr et al (2004) Various approaches for CT-guided percutaneous biopsy of deep pelvic lesions: anatomic and technical considerations. Radiographics 24:175–189CrossRefPubMed Gupta S, Nguyen HL, Morello FA Jr et al (2004) Various approaches for CT-guided percutaneous biopsy of deep pelvic lesions: anatomic and technical considerations. Radiographics 24:175–189CrossRefPubMed
20.
go back to reference Papanicolaou N, Eisenberg PJ, Silverman SG et al (1996) Prostatic biopsy after proctocolectomy: a transgluteal, CT-guided approach. Am J Roentgenol 166:1332–1334CrossRef Papanicolaou N, Eisenberg PJ, Silverman SG et al (1996) Prostatic biopsy after proctocolectomy: a transgluteal, CT-guided approach. Am J Roentgenol 166:1332–1334CrossRef
21.
go back to reference Rodríguez LV, Terris MK (1998) Risks and complications of transrectal ultrasound guided prostate needle biopsy: a prospective study and review of the literature. J Urol 160:2115–2120CrossRefPubMed Rodríguez LV, Terris MK (1998) Risks and complications of transrectal ultrasound guided prostate needle biopsy: a prospective study and review of the literature. J Urol 160:2115–2120CrossRefPubMed
22.
go back to reference Valerio M, Ahmed HU, Emberton M et al (2014) The role of focal therapy in the management of localised prostate cancer: a systematic review. Eur Urol 66:732–751CrossRefPubMedPubMedCentral Valerio M, Ahmed HU, Emberton M et al (2014) The role of focal therapy in the management of localised prostate cancer: a systematic review. Eur Urol 66:732–751CrossRefPubMedPubMedCentral
23.
go back to reference Overduin CG, Jenniskens SF, Sedelaar JP, et al (2017) Percutaneous MR-guided focal cryoablation for recurrent prostate cancer following radiation therapy: retrospective analysis of iceball margins and outcomes. Eur Radiol 27:4828–36 Overduin CG, Jenniskens SF, Sedelaar JP, et al (2017) Percutaneous MR-guided focal cryoablation for recurrent prostate cancer following radiation therapy: retrospective analysis of iceball margins and outcomes. Eur Radiol 27:4828–36
Metadata
Title
Feasibility study of MR-guided transgluteal targeted in-bore biopsy for suspicious lesions of the prostate at 3 Tesla using a freehand approach
Authors
Frank Fischbach
Lukas Wien
Sascha Krueger
Bernhard Schnackenburg
Daniel Baumunk
Björn Friebe
Martin Schostak
Jens Ricke
Katharina Fischbach
Publication date
01-06-2018
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 6/2018
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-017-5187-z

Other articles of this Issue 6/2018

European Radiology 6/2018 Go to the issue